The (POGO) Blog
April 3, 2017
Questions for Trump’s FDA Nominee
President Donald Trump’s nominee to head the Food and Drug Administration has deep roots in the pharmaceutical industry he would oversee.
Continue Reading Questions for Trump’s FDA Nominee
Topics: Public Health and Science
March 3, 2017
Trump’s Dangerous Prescription for the FDA
President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.
Continue Reading Trump’s Dangerous Prescription for the FDA
Topics: Government Accountability, Open Government, Public Health and Science
August 12, 2016
UPDATE: DOJ Subpoenas Maker of Faulty Blood Testing Devices Spotlighted by POGO
Alere Inc., maker of faulty INRatio blood testing devices, said it has received a Justice Department subpoena for records related to the devices’ accuracy and “interactions with the FDA.”
Continue Reading UPDATE: DOJ Subpoenas Maker of Faulty Blood Testing Devices Spotlighted by POGO
Topics: Government Accountability, Public Health and Science
July 13, 2016
FDA Says Faulty Devices Had "Minimal" Impact on Trial Led by New Boss
The FDA said faulty INRatio blood testing devices had “minimal” impact on a clinical trial of blood thinner Xarelto that FDA head Robert Califf co-chaired.
Continue Reading FDA Says Faulty Devices Had "Minimal" Impact on Trial Led by New Boss
Topics: Government Accountability, Public Health and Science
July 13, 2016
Faulty Blood Testing Devices to Be Withdrawn from Market
Alere, maker of INRatio blood testing devices whose potentially fatal flaws POGO spotlighted, said it is taking the machines off the market.
Continue Reading Faulty Blood Testing Devices to Be Withdrawn from Market
Topics: Government Accountability, Public Health and Science
